March 11, 2023

Investor Rights Law Firm Reminds Catalent, Inc. Investors of Important Deadline Introduction: In a recent announcement, Rosen Law Firm, a leading global investor rights law firm, has reminded purchasers of Catalent, Inc. securities about an upcoming deadline. Investors who acquired securities of Catalent, Inc. between August 30, 2021 and October 31, 2022, are urged to…

Welcome to Ventyx Biosciences Update! What’s the Buzz About Silicon Valley Bank? Hey there, fellow finance enthusiasts! If you haven’t heard the latest news, Silicon Valley Bank has been shut down by the California Department of Financial Protection and Innovation. That’s right, the FDIC is stepping in as receiver. So, what does this mean for…

Attention Bioventus Inc. Investors: Don’t Miss the March 13th Deadline for Securities Class Action New York- March 11, 2023- Globe Newswire Reminder for Bioventus Inc. Investors Rosen Law Firm, a prominent global investor rights law firm, is issuing a crucial reminder to all investors who have purchased stock in Bioventus Inc. (NASDAQ: BVS). This reminder…

Welcome to the Era of Investment in HBCUs The Push for Equality in Education It’s an exciting time to be a student at a Historically Black College or University (HBCU) thanks to President Biden’s recent budget proposal for FY 2024. The administration’s commitment to investing in HBCUs and their students is a beacon of hope…

Immix Biopharma: No Exposure to Silicon Valley Bank or Silvergate Bank Confirmed – A Heartfelt Update LOS ANGELES, March 10, 2023 Immix Biopharma, Inc. (Nasdaq: IMMX), also known as ImmixBio, is a leading biopharmaceutical company that specializes in Tissue-Specific Therapeutics (TSTx)™ targeting oncology and immuno-dysregulated diseases. In a recent update, the company has confirmed that…